Latest News about CRSP
Recent news which mentions CRSP
UK Approves First Crispr Gene Edited Therapy For Sickle Cell Disease, Beta Thalassemia
November 16, 2023
From Benzinga
Why Palo Alto Networks Shares Are Trading Lower By Around 5%; Here Are 20 Stocks Moving Premarket
November 16, 2023
From Benzinga
Tickers
CRSP
From Motley Fool
Invest in the Future With These 7 Forever Stocks
November 15, 2023
Tags
CRSP
MDT
NYSE:MDT,OTCMKTS:NTDOY,OTCMKTS:NTDOF,NASDAQ:TLRY,NYSE:CHPT,NASDAQ:CRSP,NASDAQ:RKLB,NYSE:SN
From InvestorPlace
3 Biotech Stocks With Key Catalysts Coming in December
November 15, 2023
From InvestorPlace
2 Stocks to Buy Hand Over Fist as the S&P 500 Rockets Higher
November 14, 2023
From Motley Fool
3 Biotech Stocks That Are Poised to Have Breakthroughs in 2024
November 12, 2023
From InvestorPlace
1 No-Brainer Stock to Buy and Hold for 10 Years
November 11, 2023
From Motley Fool
3 Growth Stocks to Buy Right Now Without Any Hesitation
November 11, 2023
From Motley Fool
3 Biotech Stocks That Are Betting on the Future of Gene Editing
November 09, 2023
From InvestorPlace
This Program for a Common Problem May Be Vertex Pharmaceuticals' Ticket to a New Wave of Billion-Dollar Revenues
November 09, 2023
From Motley Fool
3 Biotech Stocks With the Strongest Clinical Pipelines
November 08, 2023
From InvestorPlace
Why CRISPR Therapeutics Stock Could Be About to Take Off
November 08, 2023
Tickers
CRSP
From Motley Fool
Why CRISPR Therapeutics Stock Crushed the Market Today
November 07, 2023
Tickers
CRSP
From Motley Fool
7 Tech Stocks to Buy and Hold for the Next 25 Years
November 05, 2023
From InvestorPlace
2 Magnificent Growth Stocks That Might Be Badly Mispriced Right Now
November 05, 2023
From Motley Fool
Why CRISPR Therapeutics Stock Charged Northward This Week
November 03, 2023
Tickers
CRSP
From Motley Fool
Here's What Investors Need to Know About Vertex Pharmaceuticals and CRISPR Therapeutics' Big Day at the FDA
November 03, 2023
From Motley Fool
3 Healthcare Stocks to Buy Hand Over Fist in November
November 03, 2023
From Motley Fool
One Month Ahead of its Most Crucial Moment Ever, Should You Buy CRISPR Therapeutics?
November 02, 2023
From Motley Fool
Crispr Therapeutics’ stock soars as FDA-panel meeting raises hopes sickle-cell-disease drug will be approved
November 01, 2023
From MarketWatch
Why Are Stocks Up Today?
November 01, 2023
From InvestorPlace
Why Is Aldeyra Therapeutics (ALDX) Stock Up 40% Today?
November 01, 2023
From InvestorPlace
CRSP Stock Alert: Can CRISPR Therapeutics Short Squeeze Higher?
November 01, 2023
Tickers
CRSP
From InvestorPlace
AMD, CRISPR Therapeutics, Paycom Software, DraftKings, Tesla: Why These 5 Stocks Are On Investors' Radars Today
October 31, 2023
From Benzinga
CRSP Stock Halt: CRISPR Trading Halted Ahead of FDA Decision
October 31, 2023
Tickers
CRSP
From InvestorPlace
Gene Therapy Could Be On the Cusp of a Major Breakthrough, but Investors May Have to Remain Patient
October 30, 2023
From Motley Fool
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.